Table II. TRAEs, SAEs, and DLTs.
Adverse Event | Any Grade | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
---|---|---|---|---|---|
Any | 20 | 17 | 13 | 3 | 2 |
Abdominal pain | 2 | 1 | 1a | ||
Allergic reaction | 1 | 1a | |||
Anemia | 8 | 7 | 1 | ||
Constipation | 2 | 2 | |||
Cough | 1 | 1 | |||
Diarrhea | 2 | 2 | |||
Fatigue | 7 | 6 | 1 | ||
Fever/Chills | 5 | 5b | |||
Hyperglycemia | 1 | 1 | |||
Hypoalbuminemia | 2 | 1 | 1 | ||
Hypocalcemia | 6 | 3 | 3 | ||
Hypokalemia | 3 | 3 | |||
Hyponatremia | 4 | 4 | |||
Hypomagnesemia | 2 | 2 | |||
Injection-site reaction | 2 | 1c | 1 | ||
Leukopenia, not specified | 5 | 3 | 1 | 1 | |
Lymphopenia | 4 | 1 | 3 | ||
Nausea | 3 | 3 | |||
Neutropenia | 7 | 3 | 4c | 1c | |
Musculoskeletal pain | 3 | 2 | 1 | ||
Shortness of breath | 2 | 1 | 1a | ||
Strep throat | 1 | 1 | |||
Thrombocytopenia | 2 | 1 | 1 | ||
Upper respiratory infection | 1 | 1 |
Additional grade 1 events were observed in one patient: alanine aminotransferase increase, aspartate aminotransferase increase, creatinine increase, headache, hypermagnesemia, hypotension, rhinitis, sensory neuropathy, shortness of breath, urinary tract infection, and weight loss.
SAEs: hospitalization for abdominal pain (n = 1), unrelated to treatment; hospitalization for shortness of breath (n = 1), unrelated to treatment; and allergic reaction to leukocyte growth factor (n = 1), patient removed from study.
Regimen was interrupted (fever [n = 1]).
DLTs: neutropenia (n = 3), dose reduced; injection-site reaction (n = 1), therapy discontinued.